Latest Camber Capital Management LP Stock Portfolio
$1.07Billion | No. of Holdings #23
Camber Capital Management LP Performance
2025 Q2-7.71%
YTD-9.25%
2024+3.62%
About Camber Capital Management LP and 13F Hedge Fund Stock Holdings
On 2025-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Camber Capital Management LP reported an equity portfolio of $1.1 Billions as of 30 Jun, 2025. <br><br> The top stock holdings of Camber Capital Management LP are ZBH, BAX, HUM. The fund has invested 8.6% of it's portfolio in ZIMMER BIOMET HOLDINGS INC and 8.1% of portfolio in BAXTER INTL INC. <br><br> The fund managers got completely rid off PTC THERAPEUTICS INC (PTCT), THE CIGNA GROUP (CI) and QIAGEN NV stocks. They significantly reduced their stock positions in ANAPTYSBIO INC (ANAB), CONCENTRA GROUP HOLDINGS PAR and EVOLENT HEALTH INC (EVH). Camber Capital Management LP opened new stock positions in ICON PLC, MERCK & CO INC (MRK) and UNITEDHEALTH GROUP INC (UNH). The fund showed a lot of confidence in some stocks as they added substantially to BIOMARIN PHARMACEUTICAL INC (BMRN).
Camber Capital Management LP Equity Portfolio Value
Last Reported on: 14 Aug, 2025
$1.07Billion
as of Aug 14, 2025Camber Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Camber Capital Management LP made a return of -7.71% in the last quarter. In trailing 12 months, it's portfolio return was -10.39%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| icon plc | 43,635,000 |
| merck & co inc | 39,580,000 |
| unitedhealth group inc | 31,197,000 |
| apellis pharmaceuticals inc | 14,713,500 |
New stocks bought by Camber Capital Management LP
Additions
| Ticker | % Inc. |
|---|---|
| biomarin pharmaceutical inc | 20.00 |
Additions to existing portfolio by Camber Capital Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| anaptysbio inc | -83.33 |
| concentra group holdings par | -75.00 |
| evolent health inc | -71.67 |
| denali therapeutics inc | -68.00 |
| brookdale sr living inc | -65.6 |
| viatris inc | -63.33 |
| humana inc | -58.62 |
| zimmer biomet holdings inc | -55.56 |
Camber Capital Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| ptc therapeutics inc | -76,440,000 |
| qiagen nv | -56,210,000 |
| 10x genomics inc | -8,730,000 |
| sarepta therapeutics inc | -51,056,000 |
| ionis pharmaceuticals inc | -21,873,200 |
| moonlake immunotherapeutics | -17,229,900 |
| structure therapeutics inc | -5,193,000 |
| the cigna group | -65,800,000 |
Camber Capital Management LP got rid off the above stocks
Sector Distribution
Camber Capital Management LP has about 86.8% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 86.8 |
| Others | 13.2 |
Market Cap. Distribution
Camber Capital Management LP has about 68% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- UNALLOCATED
- MID-CAP
- MEGA-CAP
- SMALL-CAP
| Category | % |
|---|---|
| LARGE-CAP | 58.1 |
| UNALLOCATED | 13.2 |
| MID-CAP | 12.2 |
| MEGA-CAP | 9.9 |
| SMALL-CAP | 5.6 |
Stocks belong to which Index?
About 73.6% of the stocks held by Camber Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
- S&P 500
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| S&P 500 | 63.4 |
| Others | 26.5 |
| RUSSELL 2000 | 10.2 |
Camber Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Camber Capital Management LP
Camber Capital Management LP has 23 stocks in it's portfolio. About 53.2% of the portfolio is in top 10 stocks. ZBH proved to be the most loss making stock for the portfolio. EVH was the most profitable stock for Camber Capital Management LP last quarter.
$717.90MTotal Value
32.00Positions
14 Aug, 2025Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Anaptysbio Inc Anaptysbio IncANAB Camber Capital Management LP's holding in Anaptysbio Inc over time | 0.26% | 125,000 | $2.77M 0.26% | 83.33%decreased 83.33 percentreduced | |
 Apellis Pharmaceuticals Inc Camber Capital Management LP's holding in Apellis Pharmaceuticals Inc over time | 1.38% | 850,000 | $14.71M 1.38% | Newnew position | |
 Baxter Intl Inc Camber Capital Management LP's holding in Baxter Intl Inc over time | 8.1% | 2,850,000 | $86.30M 8.1% | 50.43%decreased 50.43 percentreduced | |
 Brookdale Sr Living Inc Camber Capital Management LP's holding in Brookdale Sr Living Inc over time | 1.41% | 2,150,000 | $14.96M 1.41% | 65.6%decreased 65.6 percentreduced | |
 Biomarin Pharmaceutical Inc Camber Capital Management LP's holding in Biomarin Pharmaceutical Inc over time | 3.1% | 600,000 | $32.98M 3.1% | 20%increased 20 percentadded | |
 The Cigna Group Camber Capital Management LP's holding in The Cigna Group over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Cvs Health Corp Camber Capital Management LP's holding in Cvs Health Corp over time | 6.8% | 1,050,000 | $72.43M 6.8% | 53.33%decreased 53.33 percentreduced | |
 Denali Therapeutics Inc Camber Capital Management LP's holding in Denali Therapeutics Inc over time | 0.52% | 400,000 | $5.60M 0.52% | 68%decreased 68 percentreduced | |
 Evolent Health Inc Camber Capital Management LP's holding in Evolent Health Inc over time | 0.9% | 850,000 | $9.57M 0.9% | 71.67%decreased 71.67 percentreduced | |
 Globus Med Inc Globus Med IncGMED Camber Capital Management LP's holding in Globus Med Inc over time | 4.43% | 800,000 | $47.22M 4.43% | 36%decreased 36 percentreduced | |
 Humana Inc Humana IncHUM Camber Capital Management LP's holding in Humana Inc over time | 6.88% | 300,000 | $73.34M 6.88% | 58.62%decreased 58.62 percentreduced | |
 Inogen Inc Inogen IncINGN Camber Capital Management LP's holding in Inogen Inc over time | 0.64% | 975,000 | $6.85M 0.64% | 0%unchanged 0 percentunchanged | |
 Ionis Pharmaceuticals Inc Camber Capital Management LP's holding in Ionis Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Moonlake Immunotherapeutics Camber Capital Management LP's holding in Moonlake Immunotherapeutics over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Merck & Co Inc Camber Capital Management LP's holding in Merck & Co Inc over time | 3.72% | 500,000 | $39.58M 3.72% | Newnew position | |
 Myriad Genetics Inc Camber Capital Management LP's holding in Myriad Genetics Inc over time | 1% | 2,000,000 | $10.62M 1% | 14.89%decreased 14.89 percentreduced | |
 Orasure Technologies Inc Camber Capital Management LP's holding in Orasure Technologies Inc over time | 0.25% | 900,000 | $2.70M 0.25% | 0%unchanged 0 percentunchanged | |
 Pfizer Inc Pfizer IncPFE Camber Capital Management LP's holding in Pfizer Inc over time | 3.41% | 1,500,000 | $36.36M 3.41% | 40%decreased 40 percentreduced | |
 Ptc Therapeutics Inc Camber Capital Management LP's holding in Ptc Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Sarepta Therapeutics Inc Camber Capital Management LP's holding in Sarepta Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |